# Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C

> **NCT00298714** · PHASE4 · COMPLETED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 20 (—)

## Conditions studied

- Chronic Hepatitis C
- Liver Fibrosis

## Interventions

- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT00298714
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** 20 (—)
- **Last updated:** 2007-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00298714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00298714, "Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00298714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*